Image
main content start
About Us
ADA Newsroom
Get the latest news from ADA, including press releases and research announcements.
Press Releases
If you are looking for ADA press releases issued prior to 2019, please email press@diabetes.org.
Recent Press release
Press release
New Formulations of GLP-1s Demonstrate Positive Results, Potentially Offering Additional Options for Obesity Medications
Data reveals potential for once-daily oral and monthly
Press release
Mifepristone Shown to Reduce A1C in Patients with Difficult-to-Control Type 2 Diabetes and Hypercortisolism
Study Results Signal Paradigm Shift in Diabetes Care for
Press release
New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation
Research indicates potential for new wave of…
Official Statement
Recent Press release
Official Statement
The American Diabetes Association Statement on Fighting for Federal Funding for Critical Diabetes Research and Prevention Programs
The American Diabetes Association has issued the…
Official Statement
The American Diabetes Association’s Statement on House of Representatives Passage of H.R.1 - One Big Beautiful Bill Act
Medicaid and Supplemental Nutrition Assistance Program (…
Official Statement
The American Diabetes Association’s Statement on Protecting Access to Health Care Coverage and Nutrition Assistance Programs for People with Diabetes and Obesity
Medicaid and SNAP provide critical access to care
Local Press Releases
Recent Press release
Local Press Release
2025 Tour de Cure: Finger Lakes Region Finds a New Home at Stokoe Farms
Cycling event raises funds to support diabetes research
Local Press Release
2025 Tour de Cure: Minnesota Returns to Boom Island Park
Cycling event raises funds to support diabetes research
Local Press Release
The American Diabetes Association Is Hosting Step Out: Atlanta for the First Time Since 2015
For the first time in 10 years, the American Diabetes
Advocacy News
Recent Press release
Advocacy News
Statement from the American Diabetes Association on Nevada’s Action to Cap Insulin Costs
This week, Nevada became the 28 th state to approve
Advocacy News
The American Diabetes Association Applauds Governor Jared Polis for Signing the Diabetes Prevention & Obesity Treatment Act (SB25-048) Into Law
This week, Governor Jared Polis signed the Diabetes
Advocacy News
American Diabetes Association Applauds Passage of First-Ever Law Prohibiting Step Therapy for Insulin
Today, Maryland Governor Wes Moore signed Senate Bill 646…
Press release
New Formulations of GLP-1s Demonstrate Positive Results, Potentially Offering Additional Options for Obesity Medications
Data reveals potential for once-daily oral and monthly injectable treatment alternatives for patients with type 2 diabetes and obesity
Press release
Mifepristone Shown to Reduce A1C in Patients with Difficult-to-Control Type 2 Diabetes and Hypercortisolism
Study Results Signal Paradigm Shift in Diabetes Care for Patients with Difficult-to-Control Type 2 Diabetes New findings from the…
Press release
New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation
Research indicates potential for new wave of breakthroughs in maintaining lean mass for patients taking GLP-1-based medications Findings
Press release
CagriSema Demonstrates Significant Weight Loss in Adults with Obesity
Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes Findings
Press release
Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes
Findings Highlight Potential for Novel Approach to Insulin Delivery in Pediatric Population Today, a new study demonstrates inhaled…
Press release
Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes
Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s A recent study found that oral semaglutide offers
Press release
Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy
Once-weekly insulin helped patients achieve an average A1C of 6.92% in QWINT-1 trial Results support once-weekly insulin as effective
Press release
The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care
This challenge Kickstarts additional investments through the new ADA Innovation Fund As the American Diabetes Association® (ADA)…
Press release
Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes
Common obesity drug reduced the risk of disease progression by 54% Today, a new analysis demonstrates the vascular benefits of…
Meet Our Experts
The American Diabetes Association is proud to partner with leading experts in the field of diabetes—each one directed to advancing the treatment and prevention of this disease.
Image
Charles D. Henderson
Chief Executive Officer
Image
Lisa Murdock
Chief Advocacy Officer
Image
Nuha El Sayed, MD, MMSc
Senior Vice President, Health Care Improvement
Image
Marlon Pragnell, PhD
Vice President, Research & Science
Image
Crystal Woodward, MPS
Managing Director, Legal Advocacy/Safe at School
Give Today and Change lives!
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.